Matthew M Loar - Net Worth and Insider Trading

Matthew M Loar Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew M Loar owns 4 companies in total, including Oncotelic Therapeutics Inc (OTLC) , Paratek Pharmaceuticals Inc (PRTK) , and Neurobiological Technologies Inc (NTII) among others .

Click here to see the complete history of Matthew M Loar’s form 4 insider trades.

Insider Ownership Summary of Matthew M Loar

Ticker	Comapny	Transaction Date	Type of Owner
OTLC	Oncotelic Therapeutics Inc	2015-07-20	Chief Financial Officer
PRTK	Paratek Pharmaceuticals Inc	2013-12-16	director
NTII	Neurobiological Technologies Inc	2008-10-22	VP and Chief Financial Officer
		2006-09-01	Chief Financial Officer

Matthew M Loar Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew M Loar Ownership Network

Ownership Network List of Matthew M Loar

No Data

Ownership Network Relation of Matthew M Loar

Matthew M Loar Owned Company Details

What does Oncotelic Therapeutics Inc do?

Who are the key executives at Oncotelic Therapeutics Inc?

Matthew M Loar is the Chief Financial Officer of Oncotelic Therapeutics Inc. Other key executives at Oncotelic Therapeutics Inc include CHIEF EXECUTIVE OFFICER Vuong Trieu , CHIEF BUSINESS OFFICER Saran Saund , and CHIEF FINANCIAL OFFICER Amit B. Shah .

Oncotelic Therapeutics Inc (OTLC) Insider Trades Summary

Over the past 18 months, Matthew M Loar made no insider transaction in Oncotelic Therapeutics Inc (OTLC). Other recent insider transactions involving Oncotelic Therapeutics Inc (OTLC) include a net purchase of 1,226,888 shares made by Vuong Trieu ,

In summary, during the past 3 months, insiders sold 0 shares of Oncotelic Therapeutics Inc (OTLC) in total and bought 500,000 shares, with a net purchase of 500,000 shares. During the past 18 months, 0 shares of Oncotelic Therapeutics Inc (OTLC) were sold and 1,226,888 shares were bought by its insiders, resulting in a net purchase of 1,226,888 shares.

Oncotelic Therapeutics Inc (OTLC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oncotelic Therapeutics Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Matthew M Loar is the director of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Matthew M Loar made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does Neurobiological Technologies Inc do?

Who are the key executives at Neurobiological Technologies Inc?

Matthew M Loar is the VP and Chief Financial Officer of Neurobiological Technologies Inc. Other key executives at Neurobiological Technologies Inc include 10 percent owner Ariel Warszawski , 10 percent owner Ryan Heslop , and 10 percent owner Firefly Management Co Gp, Llc .

Neurobiological Technologies Inc (NTII) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neurobiological Technologies Inc (NTII) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurobiological Technologies Inc (NTII) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neurobiological Technologies Inc (NTII)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neurobiological Technologies Inc Insider Transactions

No Available Data

What does Osteologix Holdings PLC do?

Who are the key executives at Osteologix Holdings PLC?

Matthew M Loar is the Chief Financial Officer of Osteologix Holdings PLC. Other key executives at Osteologix Holdings PLC include CEO and President Philip J Young , and director & CEO & President Charles J Casamento .

Osteologix Holdings PLC (OLGXF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Osteologix Holdings PLC (OLGXF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Osteologix Holdings PLC (OLGXF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Osteologix Holdings PLC (OLGXF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Osteologix Holdings PLC Insider Transactions

No Available Data

Matthew M Loar Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew M Loar. You might contact Matthew M Loar via mailing address: 505 Penobscot Dr, Redwood City Ca 94063.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.